Moderna
MRNA
#1350
Rank
NZ$23.05 B
Marketcap
$59.76
Share price
-2.58%
Change (1 day)
-61.93%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2024 (TTM): -NZ$3.87 Billion

According to Moderna 's latest financial reports the company's current earnings are NZ$5.05 Billion. In 2023 the company made an earning of -NZ$6.81 Billion a decrease over its 2022 earnings that were of NZ$16.73 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$3.87 Billion-43.11%
2023 -NZ$6.81 Billion-140.65%
2022 NZ$16.73 B-27.81%
2021 NZ$23.17 B-1911.15%
2020 -NZ$1.28 Billion44.7%
2019 -NZ$0.89 Billion28.63%
2018 -NZ$0.69 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$72.08 Million-98.22%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$26.08 B-742.89%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$72.77 Million-98.21%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.42 Billion-89.89%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$23.76 B-685.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-NZ$1.05 Billion-74.23%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$30.38 B-848.91%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.21 Billion-94.95%๐Ÿ‡บ๐Ÿ‡ธ USA